Prime Medicine, Common Etf Price on January 2, 2024

PRME Etf  USD 3.30  0.04  1.20%   
If you're considering investing in Prime Etf, it is important to understand the factors that can impact its price. As of today, the current price of Prime Medicine, stands at 3.30, as last reported on the 29th of November, with the highest price reaching 3.39 and the lowest price hitting 3.28 during the day. Prime Medicine, Common maintains Sharpe Ratio (i.e., Efficiency) of -0.0239, which implies the entity had a -0.0239% return per unit of risk over the last 3 months. Prime Medicine, Common exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Prime Medicine,'s Risk Adjusted Performance of (0.03), coefficient of variation of (1,865), and Variance of 26.27 to confirm the risk estimate we provide.
  
Prime Etf price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0239

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPRME

Estimated Market Risk

 5.09
  actual daily
45
55% of assets are more volatile

Expected Return

 -0.12
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Prime Medicine, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Prime Medicine, by adding Prime Medicine, to a well-diversified portfolio.
Price Book
2.284
Enterprise Value Ebitda
(3.10)
Price Sales
541.0391
Shares Float
60.4 M
Wall Street Target Price
12.6364

Related Headline

Theseus Pharmaceuticals Headline on 24th of July 2023

Theseus Pharmaceuticals Inc is lower by 3.62 percent Monday In Premarket Trading InvestorsObserver

Prime Medicine, Valuation on January 2, 2024

It is possible to determine the worth of Prime Medicine, on a given historical date. On January 2, 2024 Prime was worth 8.83 at the beginning of the trading date compared to the closed value of 8.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Prime Medicine, etf. Still, in general, we apply an absolute valuation method to find Prime Medicine,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Prime Medicine, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Prime Medicine,'s related companies.
 Open High Low Close Volume
  9.51    9.52    8.85    8.86    314,900  
01/02/2024
  8.83    9.24    8.50    8.76    486,600  
  8.70    8.99    8.43    8.87    325,300  
Backtest Prime Medicine,  |  Prime Medicine, History  |  Prime Medicine, Valuation   PreviousNext  
Open Value
8.83
8.76
Closing Value
24.10
Upside

Prime Medicine, Trading Date Momentum on January 2, 2024

On January 03 2024 Prime Medicine, Common was traded for  8.87  at the closing time. The top price for the day was 8.99  and the lowest listed price was  8.43 . The trading volume for the day was 325.3 K. The trading history from January 3, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 1.26% . The trading delta at closing time against the current closing price is 6.39% .

Prime Medicine, Common Fundamentals Correlations and Trends

By evaluating Prime Medicine,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Prime Medicine,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Prime financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Prime Medicine, Etf history

Prime Medicine, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Prime is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Prime Medicine, Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Prime Medicine, stock prices may prove useful in developing a viable investing in Prime Medicine,
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. Prime Medicine is listed under Biotechnology in the United States and is traded on NASDAQ Exchange exchange.

Prime Medicine, Quarterly Net Working Capital

208.19 Million

Prime Medicine, Etf Technical Analysis

Prime Medicine, technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of Prime Medicine, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Prime Medicine, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Prime Medicine, Period Price Range

Low
November 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Prime Medicine, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Prime Medicine, November 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Prime Medicine, etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Prime Medicine, shares will generate the highest return on investment. By undertsting and applying Prime Medicine, etf market strength indicators, traders can identify Prime Medicine, Common entry and exit signals to maximize returns

Prime Medicine, Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Prime Medicine,'s price direction in advance. Along with the technical and fundamental analysis of Prime Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Prime to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Other Information on Investing in Prime Etf

Prime Medicine, financial ratios help investors to determine whether Prime Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prime with respect to the benefits of owning Prime Medicine, security.